Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase (Q33349632)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase |
scientific article |
Statements
1 reference
Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase (English)
1 reference
Thierry Facon
1 reference
Martine Gardembas
1 reference
Philippe Rousselot
1 reference
Michel Tulliez
1 reference
Magda Vigier
1 reference
Agnes Buzyn
1 reference
Francoise Rigal-Huguet
1 reference
Laurence Legros
1 reference
Mauricette Michallet
1 reference
Christian Berthou
1 reference
Nathalie Cheron
1 reference
Frederic Maloisel
1 reference
Francois-Xavier Mahon
1 reference
Patrice Berthaud
1 reference
Joelle Guilhot
1 reference
Francois Guilhot
1 reference
CML French Group
1 reference
21 August 2003
1 reference
1 reference
102
1 reference
13
1 reference
4298-4305
1 reference
Identifiers
1 reference
1 reference